Pennvax-B: Completed Phase I enrollment

Inovio and the HIV Vaccine Trials Network completed enrollment of 48 healthy volunteers in the double-blind, placebo-controlled, U.S. Phase I HVTN-080 trial to evaluate 3 mg of Pennvax-B delivered vi...